×
About 7,351 results

ALLMedicine Acne Vulgaris Center

Research & Reviews  2,743 results

The relationship between acne vulgaris and irritable bowel syndrome: A preliminary study.
https://doi.org/10.1111/jocd.13481
Journal of Cosmetic Dermatology REFERENCES; Demirbaş A, Elmas ÖF

May 28th, 2020 - Irritable bowel syndrome (IBS) is a functional gastrointestinal disease characterized by chronic abdominal pain and changes in bowel movements without underlying organic pathology. Many skin diseases have been reported to be more common in individ...

Influence of Contraception Class on Incidence and Severity of Acne Vulgaris.
https://doi.org/10.1097/AOG.0000000000003880
Obstetrics and Gynecology; Barbieri JS, Mitra N et. al.

May 27th, 2020 - To evaluate the association of different contraceptive methods on the incidence and severity of acne. Using a de-identified commercial claims database, we performed a retrospective cohort study evaluating the incidence of clinical encounters for a...

Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
https://doi.org/10.1007/s40257-020-00523-1
American Journal of Clinical Dermatology; Paik J

May 27th, 2020 - Topical minocycline foam 4% (Amzeeq™) is approved in the USA for the treatment of inflammatory lesions of non-nodular, moderate to severe acne vulgaris (acne) in patients aged ≥ 9 years. It was developed to minimize systemic minocycline absorption...

Knowledge levels and concerns about oral isotretinoin treatment in the parents of adole...
https://doi.org/10.1111/dth.13669
Dermatologic Therapy; Kara Polat A, Akin Belli A et. al.

May 26th, 2020 - Oral isotretinoin is frequently used in the treatment of young acne patients. However, knowledge levels and attitudes about this treatment have not been studied in the parents previously. We aimed to investigate the knowledge levels and concerns a...

Comparing clinical acne vulgaris severity to adolescent and parent perceptions of acne ...
https://doi.org/10.1111/pde.14034
Pediatric Dermatology REFERENCES; Sadowsky LM, Yang CY et. al.

May 26th, 2020 - Little research has compared clinician acne severity assessment with either adolescent- or parent-rated scales of acne severity or impact on quality of life (QOL). We sought to assess how adolescents and their parents perceive the severity and imp...

see more →

Guidelines  29 results

Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
https://www.foamix.com/news-releases/news-release-details/update-foamix-receives-fda-approval-amzeeqtm-topical-minocycline

Oct 17th, 2019 - Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its novel AMZEEQTM (minocycline) topical foam, 4%. AMZEEQ, fo...

Acne Vulgaris: Diagnosis and Treatment
https://www.aafp.org/afp/2019/1015/p475.html
American Family Physician;

Oct 14th, 2019 - Acne vulgaris is the most prevalent chronic skin disease in the United States, affecting nearly 50 million people per year, mostly adolescents and young adults. Potential sequelae of acne, such as scarring, dyspigmentation, and low self-esteem, ma...

FDA approves Aklief for acne on face, trunk
https://www.healio.com/dermatology/acne/news/online/%7Bcc693b23-e6fc-4919-a303-fc14f62279b4%7D/fda-approves-aklief-for-acne-on-face-trunk

Oct 3rd, 2019 - The FDA recently approved Galderma’s topical retinoid cream, known as Aklief, for the treatment of acne vulgaris. Additionally, the company reported positive safety profiles for Aklief in two phase 3 clinical trials on acne of both the face and tr...

Oral isotretinoin for acne
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009435.pub2/full
Riera,R.,etal

Nov 23rd, 2018 - Acne vulgaris, a chronic inflammatory disease of the pilosebaceous unit associated with socialisation and mental health problems, may affect more than 80% of teenagers. Isotretinoin is the only drug that targets all primary causal factors of acne;...

Acne Vulgaris - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK459173/
Sutaria,A.,et al

Nov 13th, 2018 - Acne vulgaris is an inflammatory disorder of pilosebaceous unit, which runs a chronic course and it is self-limiting. Acne vulgaris is triggered by Propionibacterium acnes in adolescence, under the influence of normal circulating dehydroepiandrost...

see more →

Drugs  655 results see all →

Clinicaltrials.gov  3,535 results

The relationship between acne vulgaris and irritable bowel syndrome: A preliminary study.
https://doi.org/10.1111/jocd.13481
Journal of Cosmetic Dermatology REFERENCES; Demirbaş A, Elmas ÖF

May 28th, 2020 - Irritable bowel syndrome (IBS) is a functional gastrointestinal disease characterized by chronic abdominal pain and changes in bowel movements without underlying organic pathology. Many skin diseases have been reported to be more common in individ...

Influence of Contraception Class on Incidence and Severity of Acne Vulgaris.
https://doi.org/10.1097/AOG.0000000000003880
Obstetrics and Gynecology; Barbieri JS, Mitra N et. al.

May 27th, 2020 - To evaluate the association of different contraceptive methods on the incidence and severity of acne. Using a de-identified commercial claims database, we performed a retrospective cohort study evaluating the incidence of clinical encounters for a...

Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
https://doi.org/10.1007/s40257-020-00523-1
American Journal of Clinical Dermatology; Paik J

May 27th, 2020 - Topical minocycline foam 4% (Amzeeq™) is approved in the USA for the treatment of inflammatory lesions of non-nodular, moderate to severe acne vulgaris (acne) in patients aged ≥ 9 years. It was developed to minimize systemic minocycline absorption...

Knowledge levels and concerns about oral isotretinoin treatment in the parents of adole...
https://doi.org/10.1111/dth.13669
Dermatologic Therapy; Kara Polat A, Akin Belli A et. al.

May 26th, 2020 - Oral isotretinoin is frequently used in the treatment of young acne patients. However, knowledge levels and attitudes about this treatment have not been studied in the parents previously. We aimed to investigate the knowledge levels and concerns a...

Comparing clinical acne vulgaris severity to adolescent and parent perceptions of acne ...
https://doi.org/10.1111/pde.14034
Pediatric Dermatology REFERENCES; Sadowsky LM, Yang CY et. al.

May 26th, 2020 - Little research has compared clinician acne severity assessment with either adolescent- or parent-rated scales of acne severity or impact on quality of life (QOL). We sought to assess how adolescents and their parents perceive the severity and imp...

see more →

News  389 results

FDA Approvals, Highlights, and Summaries: Dermatology
https://www.medscape.com/viewarticle/925392

Feb 26th, 2020 - Aklief (trifarotene) Trifarotene is an agonist of retinoic acid receptors (RARs), with particular activity at the gamma subtype of RAR. Stimulation of RARs results in modulation of target genes that are associated with various processes, including...

CUTIS Celebrates 55 Years
https://www.mdedge.com/dermatology/article/217608/cutis-celebrates-55-years

Feb 20th, 2020 - When the first issue of Cutis was published in February 1965: Alopecia was featured on the cover Eugene F. Traub, MD, was Chief Editor, and John T.

Product News February 2020
https://www.mdedge.com/dermatology/article/217153/product-news-february-2020

Feb 12th, 2020 - Arazlo Lotion Approved for Acne Vulgaris Ortho Dermatologics announces US Food and Drug Administration approval of Arazlo (tazarotene) Lotion 0. 045% for the topical treatment of acne vulgaris in patients 9 years and older.

FDA OKs First Tazarotene Lotion (Arazlo) for Acne Vulgaris
https://www.medscape.com/viewarticle/922941

Dec 18th, 2019 - The US Food and Drug Administration (FDA) has approved tazarotene lotion 0.045% (Arazlo, Ortho Dermatologics) to treat acne vulgaris in individuals aged 9 years and older. Arazlo is the first tazarotene acne treatment available in lotion form, and...

Product News November 2019
https://www.mdedge.com/dermatology/article/211999/psoriasis?channel=38029

Nov 11th, 2019 - Aklief Cream Topical Retinoid Approved for Acne Vulgaris Galderma Laboratories, LP, announces US Food and Drug Administration approval of Aklief (trifarotene) Cream 0. 005% for the treatment of acne vulgaris in patients 9 years and older.

see more →